ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,027Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 71

$1.58M Total Retail Price of All Prescriptions

Rank: 6 out of 71

722 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 722 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

14% of this provider’s 722 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 20,530 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 30.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
FUROSEMIDE 820 676 1 1
OMEPRAZOLE 701 574 2 3
AMLODIPINE BESYLATE 698 577 3 4
LEVOTHYROXINE SODIUM 651 521 4 2
SIMVASTATIN 632 522 5 5
METOPROLOL TARTRATE 626 519 6 8
NAMENDA 589 566 7 14
DONEPEZIL HCL 589 548 7 10
LISINOPRIL 568 478 9 6
LANTUS 473 369 10 29
COUMADIN 470 470 11 103
JANTOVEN 464 328 12 43
SERTRALINE HCL 461 386 13 17
NOVOLOG 446 340 14 45
DIVALPROEX SODIUM 428 293 15 33
POTASSIUM CHLORIDE 396 363 16 11
CITALOPRAM HBR 371 298 17 12
MIRTAZAPINE 341 323 18 15
ESCITALOPRAM OXALATE 327 248 19 46
GABAPENTIN 315 235 20 13
QUETIAPINE FUMARATE 302 246 21 38
HYDROCODONE-ACETAMINOPHEN 283 222 S3 22 9
TRAMADOL HCL 265 244 23 22
WARFARIN SODIUM 255 94 24 7
CYMBALTA 252 202 25 31
LEVETIRACETAM 244 117 26 49
METOPROLOL SUCCINATE 242 225 27 16
HYDRALAZINE HCL 232 201 28 55
CARVEDILOL 229 148 29 25
RISPERIDONE 210 173 30 24
CLONIDINE HCL 203 152 31 48
TAMSULOSIN HCL 201 163 32 34
TRAZODONE HCL 199 122 33 23
PREDNISONE 188 152 34 36
CLOPIDOGREL 185 172 35 32
KLOR-CON M20 176 132 36 59
CARBIDOPA-LEVODOPA 164 137 37 66
ISOSORBIDE MONONITRATE ER 162 134 38 44
PANTOPRAZOLE SODIUM 161 126 39 40
DOXYCYCLINE HYCLATE 159 112 40 93
ATORVASTATIN CALCIUM 156 129 41 20
SANTYL 151 100 42 147
LOSARTAN POTASSIUM 150 117 43 21
ALLOPURINOL 147 124 44 41
LEVOFLOXACIN 143 113 45 63
HYDROCHLOROTHIAZIDE 138 97 46 19
LIDODERM 138 127 46 73
PROMETHAZINE HCL 137 105 R 48 85
BACLOFEN 137 46 48 67
METFORMIN HCL 135 103 50 18
OXYCONTIN 135 126 S2 50 128
PLAVIX 126 117 52 57
DIGOXIN 123 102 53 56
IPRATROPIUM-ALBUTEROL 120 91 54 60
ALENDRONATE SODIUM 120 99 54 39
ADVAIR DISKUS 119 98 56 47
METOCLOPRAMIDE HCL 117 52 57 100
RESTASIS 115 114 58 157
PHENYTOIN SODIUM EXTENDED 114 60 59 83
ENALAPRIL MALEATE 113 86 60 71
CIPROFLOXACIN HCL 112 96 61 52
ZOLPIDEM TARTRATE 109 86 62 26
FAMOTIDINE 107 59 63 78
ALBUTEROL SULFATE 106 80 64 106
DILTIAZEM 24HR CD 106 105 64 72
LOVAZA 103 49 66 144
SEROQUEL 99 81 67 92
CRESTOR 98 84 68 50
LEXAPRO 98 78 68 124
SULFAMETHOXAZOLE-TRIMETHOPRIM 97 70 70 81
OLANZAPINE 94 68 71 65
PAROXETINE HCL 93 81 72 84
AGGRENOX 92 72 73 135
DILTIAZEM HCL 90 39 74 164
LEVEMIR 89 60 75 136
FLUOXETINE HCL 86 58 76 76
DILTIAZEM 24HR ER 86 59 76 178
NEXIUM 86 38 76 42
EXELON 80 80 79 91
OXYCODONE-ACETAMINOPHEN 78 61 S2 80 51
SPIRONOLACTONE 78 55 80 58
LAMOTRIGINE 78 35 80 64
ABILIFY 76 59 83 102
KLOR-CON M10 73 61 84 88
NYSTATIN 71 65 85 97
ATENOLOL 71 58 85 30
FENTANYL 70 44 S2 87 68
RANITIDINE HCL 70 62 87 36
AVELOX 69 64 89 163
SPIRIVA 68 61 90 62
FLUTICASONE PROPIONATE 68 59 90 35
FENOFIBRATE 67 51 92 113
CEFTRIAXONE 67 52 92 104
GLIMEPIRIDE 65 45 94 74
AMOX TR-POTASSIUM CLAVULANATE 64 45 95 131
OXYCODONE HCL 64 45 S2 95 54
AZITHROMYCIN 63 53 97 53
BENAZEPRIL HCL 63 45 97 89
DILANTIN 62 32 99 172
TRAVATAN Z 59 54 100 115
OXYBUTYNIN CHLORIDE 59 21 100 112
MORPHINE SULFATE ER 59 49 S2 100 132
DORZOLAMIDE-TIMOLOL 59 51 100 244
BUDESONIDE 58 40 104 295
CELEBREX 57 57 105 170
LABETALOL HCL 57 36 105 155
CEPHALEXIN 56 47 107 87
IPRATROPIUM BROMIDE 56 40 107 205
ENOXAPARIN SODIUM 55 24 109 193
TRICOR 54 39 110 153
TORSEMIDE 54 49 110 145
TRIAMCINOLONE ACETONIDE 54 48 110 120
VENLAFAXINE HCL ER 54 42 110 82
MUPIROCIN 52 43 114 126
LUMIGAN 52 51 114 241
TERAZOSIN HCL 51 43 116 179
AMIODARONE HCL 51 32 116 216
LIDOCAINE HCL 50 34 118 176
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.